MTOR and kidney cancer: mTOR was reported to be aberrantly activated during tumorigenesis, and it was found to have played a crucial role in the initiation and progression of various malignant tumors, including breast, prostate, lung, liver, and kidney cancers (Posadas, Limvorasak & Figlin, 2017).